Skip to main content

Full Schedule

Full Schedule

  • Thursday, August 19, 2021
  • 8:00 AM – 8:55 AM
    Opening Session Should Patients with CLL Have a Treatment Break?
  • 9:10 AM – 9:55 AM
    Emerging Treatment Regimens in MCL: Pharmacy-Based Management Strategies
  • 9:55 AM – 10:10 AM
    Exhibit Hall Break
  • 10:10 AM – 10:40 AM
    Ask the Experts: Hepatitis B Screening, Prevention, and Treatment
  • 10:40 AM – 10:55 AM
    Exhibit Hall Break
  • 10:55 AM – 11:40 AM
    Management of Relapsed/Refractory Hodgkin Lymphoma
  • 11:55 AM – 12:40 PM
    Novel Medications for the Treatment of NHL: A Closer Look at Anti-CD30 Antibodies, EZH2 Inhibitors, and PI3K Inhibitors
  • 12:55 PM – 1:40 PM
    Addressing Pharmacy Challenges in Multiple Myeloma: Strategies for Overcoming Treatment Resistance
  • 1:55 PM – 2:55 PM
    Innovation Theater (non-accredited)
  • 2:55 PM – 3:10 PM
    Exhibit Hall Break
  • 3:10 PM – 3:40 PM
    Ask the Experts: Neoadjuvant Therapy for Pancreatic Cancer
  • 3:40 PM – 3:55 PM
    Exhibit Hall Break
  • 3:55 PM – 4:40 PM
    Formulary Perspectives in Myelodysplastic Syndromes and Acute Myeloid Leukemia: Novel Treatment Options for High-Risk Subtypes
  • 4:55 PM – 5:40 PM
    Pharmacy Perspectives in CLL/SLL: Navigating a Rapidly Evolving Treatment Landscape
  • 5:55 PM – 6:40 PM
    Pharmacist-Guided Strategies for Overcoming Treatment Selection and Sequencing Challenges in DLBCL
  • Friday, August 20, 2021
  • 8:00 AM – 8:50 AM
    Overview of HER2 directed therapies in Metastatic Breast Cancer
  • 9:05 AM – 9:50 AM
    HPV Vaccination: Not Just Cervical Cancer Prevention
  • 10:05 AM – 11:05 AM
    Innovation Theater (non-accredited)
  • 11:05 AM – 11:20 AM
    Exhibit Hall Break
  • 11:20 AM – 11:50 AM
    Ask the Experts: Biosimilars in Oncology Pharmacy
  • 11:50 AM – 12:05 PM
    Exhibit Hall Break
  • 12:05 PM – 12:50 PM
    To PARP or not to PARP – that is the Question
  • 1:50 PM – 2:05 PM
    Exhibit Hall Break
  • 2:05 PM – 2:35 PM
    Ask the Experts: Fludarabine, Cyclophosphamide, and Rituximab (FCR) for Chronic Lymphocytic Leukemia
  • 2:35 PM – 2:50 PM
    Exhibit Hall Break
  • 2:50 PM – 3:35 PM
    Pharmacist-Guided Therapy in NSCLC: Targeted Therapies in the Frontline Setting and Beyond
  • Saturday, August 21, 2021
  • 8:00 AM – 8:50 AM
    Personalized Medicine in Colorectal Cancer
  • 9:05 AM – 9:50 AM
    Targeted Therapies for Biliary Tract Cancers: The Oncology Pharmacist’s Role in Personalized Treatments
  • 10:05 AM – 11:05 AM
    Innovation Theater (non-accredited)
  • 11:05 AM – 11:50 AM
    Exhibit Hall Break
  • 11:50 AM – 12:50 PM
    The Role of the Pharmacist in Tailored Management of Renal Cell Carcinoma
  • 1:05 PM – 1:50 PM
    The Pharmacists Role in End of Life Transition
  • 1:50 PM – 2:05 PM
    Exhibit Hall Break
  • 2:05 PM – 2:35 PM
    Ask the Experts: COVID-19 Vaccinations
  • 2:35 PM – 2:50 PM
    Exhibit Hall Break
  • 3:50 PM – 4:35 PM
    Preventing and Managing Patient Financial Toxicity
  • Cancelled
  • Approaches for Neoadjuvant Therapy for Resectable/Borderline Resectable Pancreatic Cancer
  • Biosimilars: What's in the Pipeline
  • Combination Therapy for Metastatic Lung Cancer
  • Hepatitis B Virus Screening and Management for Patients With Cancer
  • Optimizing Patient Education: Oncology Medication
  • Sequencing of Therapy in Metastatic Urothelial Cancer and Therapy for Cisplatin-Ineligible Patients
  • Standard of Care: FCR